Though one such fragment, a C-terminally truncated ending at amino acid 368 (called Tau 368) was shown to be less altered in AD (including in Aβ-positive CU) another study however showed that the tau-368/T-tau ratio correlated with Tau PET [123]. The gene discussed is MAPT; the disease is Alzheimer disease.